Optimal use of lenvatinib in the treatment of advanced thyroid cancer
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s41199-017-0026-0
Published Online: 2017-10-24
Published Print: 2017-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Takahashi, Shunji
Kiyota, Naomi
Tahara, Makoto
Funding for this research was provided by:
Eisai Co Ltd